Updates are available Erratum dated 2020-02-01
Click to view Erratum: https://doi.org/10.1016/j.ebiom.2019.12.004
-
Authors
Hickson, LaTonya J.
Langhi Prata, Larissa G.P.
Bobart, Shane A.
Evans, Tamara K.
Giorgadze, Nino
Hashmi, Shahrukh K.
Herrmann, Sandra M.
Jensen, Michael D.
Jia, Qingyi
Jordan, Kyra L.
Kellogg, Todd A.
Khosla, Sundeep
Koerber, Daniel M.
Lagnado, Anthony B.
Lawson, Donna K.
LeBrasseur, Nathan K.
Lerman, Lilach O.
McDonald, Kathleen M.
McKenzie, Travis J.
Passos, João F.
Pignolo, Robert J.
Pirtskhalava, Tamar
Saadiq, Ishran M.
Schaefer, Kalli K.
Textor, Stephen C.
Victorelli, Stella G.
Volkman, Tammie L.
Xue, Ailing
Wentworth, Mark A.
Wissler Gerdes, Erin O.
Zhu, Yi
Tchkonia, Tamara
Kirkland, James L.
-
Funding
Funding for this research was provided by:
NIH (DK109134, DK118120, DK120292, AG013925, AG062413)
Translational Geroscience Network (DK45343, DK40484, TR002377)
Mayo Clinic Center for Translational Science Activities
Robert and Arlene Kogod, Satellite Healthcare
Connor Group
Robert J. and Theresa W. Ryan
Ted Nash Long Life
Noaber Foundations
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Journal Title: EBioMedicine
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ebiom.2019.08.069
Content Type: article
Copyright: © 2019 The Authors. Published by Elsevier B.V.
